Runhao Li

Research Interests

Cancer Biology and Clinical Oncology Regenerative medicine (incl. stem cells) Fertility Gene Expression

Mr Runhao Li

Research Associate (A) (without PhD)

School of Pharmacy and Biomedical Sciences

College of Health

Research Fellow, Reproductive Biology & spermatogonial stem cells (SSCs)  – The University of Adelaide
Dr Runhao Li is a biomedical researcher with a strong background in gene editing, stem cell biology, and translational reproductive research. He is currently a Research Fellow at the University of Adelaide, and is affiliated with the Robinson Reproductive Research Institute and the South Australian immunoGENomics Cancer Institute (SAiGENCI).

Date Position Institution name
2026 - ongoing Research Fellow University of Adelaide
2021 - 2025 Postgraduate Research student Basil Hetzel Institute for Translational Health Research

Language Competency
Chinese (Mandarin) Can read, write, speak and understand spoken
English Can read, write, speak and understand spoken

Date Institution name Country Title
2022 - 2025 University of Adelaide Australia PhD
2020 - 2021 University of Adelaide Australia Master
2014 - 2018 Liaoning University China Bachelor

Year Citation
2025 Rad, S. K., Yeo, K. K. L., Li, R., Wu, F., Liu, S., Nourmohammadi, S., . . . Smith, E. (2025). Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells. Biomolecules, 15(1), 55-1-55-17.
DOI Scopus6 WoS6 Europe PMC4
2025 Rad, S. K., Yeo, K. K. L., Wu, F., Li, R., Nourmohammadi, S., Tomita, Y., . . . Smith, E. (2025). A Systematic Review and Meta-Analysis of 16S rRNA and Cancer Microbiome Atlas Datasets to Characterize Microbiota Signatures in Normal Breast, Mastitis, and Breast Cancer. Microorganisms, 13(2), 467-1-467-24.
DOI Scopus6 WoS5 Europe PMC6
2025 Rad, S. K., Li, R., Yeo, K. K. L., Cooksley, C., Shaghayegh, G., Vreugde, S., . . . Smith, E. (2025). Cell Line-Dependent Internalization, Persistence, and Immunomodulatory Effects of Staphylococcus aureus in Triple-Negative Breast Cancer. Cancers, 17(18), 2947-1-2947-25.
DOI Scopus2 WoS3 Europe PMC1
2025 Kianpour Rad, S., Li, R., Yeo, K. K. L., Wu, F., Tomita, Y., Price, T. J., . . . Smith, E. (2025). Bacterial Infections and Their Cell Wall Ligands Differentially Modulate Doxorubicin Sensitivity in Triple-Negative Breast Cancer Cells. Microorganisms, 13(10), 17 pages.
DOI WoS1
2024 Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?. Pathogens, 13(10), 826-1-826-20.
DOI Scopus3 WoS3 Europe PMC3
2024 Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11.
DOI Scopus15 WoS12 Europe PMC10
2024 Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16.
DOI Scopus2 WoS1 Europe PMC2
2024 Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. Journal of Medical Microbiology, 73(2), 001799-1-001799-18.
DOI Scopus6 WoS5 Europe PMC7
2024 Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), e7352-1-e7352-11.
DOI Europe PMC1
2023 Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages.
DOI Scopus3 WoS3 Europe PMC3
2023 Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17.
DOI Scopus19 WoS18 Europe PMC17
2022 Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages.
DOI Scopus13 WoS14 Europe PMC13

Year Citation
2025 Rad, S. K., Yeo, K., Wu, F., Li, R., Nourmohammadi, S., Tomita, Y., . . . Smith, E. (2025). Systematic Review and Meta-Analysis of 16S rRNA and Cancer Microbiome Atlas Datasets to Characterize Microbiota Signatures in Normal Breast, Mastitis and Breast Cancer.
DOI
2025 Kianpour Rad, S., Li, R., Yeo, K., Wu, F., Tomita, Y., Price, T., . . . Smith, E. (2025). Bacterial Infection and Their Cell Wall Ligands Differentially Modulate Doxorubicin Sensitivity in Triple‐Negative Breast Cancer Cells.
DOI
2025 Rad, S. K., Li, R., Yeo, K., Cooksley, C., Shaghayegh, G., Vreugde, S., . . . Smith, E. (2025). Cell Line-Dependent Internalization, Persistence, and Immunomodulatory Effects of Staphylococcus aureus in Triple-Negative Breast Cancer.
DOI
2024 Rad, S. K., Yeo, K., Li, R., Wu, F., Liu, S., Nourmohammadi, S., . . . Smith, E. (2024). Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells.
DOI
2024 Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?.
DOI
2024 Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease.
DOI

Connect With Me

External Profiles

Other Links